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Introduction
Hyperlactatemia is often associated with poor clinical
outcomes. Mortality is increased when lactic acidosis
with low-flow states or sepsis. For improving poor prog-
nosis, early detection and intervention of hyperlactatemia
are important. There are call for monitoring blood lactate
level. However, hyperlactatemia is often associated with
type II lactic acidosis in hemato-oncologic malignant
patients.
Objectives
We investigate there are difference in blood lactate level
between severe sepsis and Type II lactic acidosis in
hemato-oncologic malignant patients.
Methods
Medical records of 99 patients in hemato-oncologic
malignant patients admitted at Asan Medical Center
from January 1, 2013 to June 31, 2013 was reviewed.
Above 4 mmol/L blood lactate were screening.
Results
Among 99 patients with hyperlactatemia, 35 patients
showed severe sepsis, 64 patients showed Type II lactic
acidosis. There was no significant difference in basal
characteristics. Blood lactate level was no significant dif-
ference (6.76 mmol/L in severe sepsis and 6.10 mmol/L
in type II lactic acidosis, P-value = 0.301). There are sig-
nificant difference in blood lactate level between oncolo-
gic malignant patients and hematologic malignant
patients (6.63 mmol/L and 5.48 mmol/L, P-value =
0.029). In oncologic malignant patients, blood lactate
level was no significant difference between severe sepsis
and type II lactic acidosis (7.26 mmol/L and 6.32 mmol/L,
P-value = 0.291). In hematologic malignant patients, blood
lactate level was no significant difference between severe
sepsis and type II lactic acidosis (5.67 mmol/L and
5.32 mmol/L, P-value = 0.639)
Conclusions
Hyperlactatemis is associated with poor prognosis. It is
important blood lactate level screening in severe sepsis.
However, blood lactate level is not useful with hemato-
oncologic malignant patients for sepsis screening. Other
indicators to suggest sepsis are more useful sepsis screen-
ing tool. For example, other indicator were blood pressure,
heart rate, respiratory rate, body temperature, mental sta-
tus, oxygen requirement and urine output etc.
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